Side-by-side comparison of AI visibility scores, market position, and capabilities
YC-backed AI renewable energy developer finding profitable land/grid connections for solar and wind projects before competitors; addressing the 80-90% early-stage project failure rate as US needs 2,000 GW new capacity by 2035 for AI data centers.
Astro is a United States-based AI-powered renewable energy development company — backed by Y Combinator — building the first AI platform that de-risks and accelerates the early-stage development of solar, wind, and battery storage energy projects for the US market, identifying profitable land sites and grid connections for new gigawatt-scale renewable projects that traditional energy developers miss. Astro addresses a critical bottleneck in the US energy transition: the country needs an estimated 2,000 gigawatts of new renewable generation capacity by 2035 to power AI data centers, electric vehicles, and building electrification — but 80-90% of renewable energy projects fail in early development due to unexpected interconnection costs and grid constraints that developers only discover after spending months and millions on site acquisition and environmental studies.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.